メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
加藤 将
教授
内科学（第一）講座
https://sandbox.orcid.org/0000-0002-2023-6585
h-index
3851
被引用数
23
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2008
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(117)
コース
(1)
類似のプロファイル
(1)
フィンガープリント
Masaru Katoが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Immunology and Microbiology
Inflammatory Arthritis
100%
Antiphospholipid Syndrome
67%
Tocilizumab
48%
Fibroblast
45%
Systemic Lupus Erythematosus
44%
Antiphospholipid Antibody
42%
Prothrombin Antibody
39%
Connective Tissue
38%
Lung Artery Pressure
37%
Systemic Scleroderma
34%
ANCA Associated Vasculitis
28%
Granulomatosis with Polyangiitis
28%
Prevalence
27%
Microscopic Polyangiitis
26%
Autophagy
25%
Immunoglobulin M
24%
Lupus Erythematosus
24%
Cell Death
24%
Hepatitis E Virus
22%
Vasculitis
22%
Methotrexate
22%
Rheumatic Disease
22%
Glucocorticoid
20%
Glycoprotein
15%
Enzyme-Linked Immunosorbent Assay
15%
Cytokine
15%
Arthritis
15%
Neutrophil Cytoplasmic Antibody
14%
Downregulation
14%
Viral Disease
13%
Methylprednisolone
12%
Immunosuppressive Drug
12%
Pulse Rate
12%
Epigenetics
11%
Dermatomyositis
11%
Giant Cell Arteritis
11%
Anti-Citrullinated Protein Antibody
11%
interferon
11%
Virus Reactivation
11%
Fibroblast-Like Synoviocyte
11%
Thromboplastin
11%
Rituximab
11%
Lupus Vulgaris
11%
Antibody Titer
11%
Tyrosine
11%
Enteritis
11%
Functional Connectivity
11%
Anterior Cingulate
11%
Apolipoprotein
11%
Low-Density Lipoprotein
11%
Medicine and Dentistry
Pulmonary Hypertension
97%
Inflammatory Arthritis
58%
Rheumatoid Arthritis
58%
Systemic Lupus Erythematosus
53%
Systemic Scleroderma
45%
Connective Tissue Disease
40%
ANCA Associated Vasculitis
32%
Glucocorticoid
32%
Cardiac Magnetic Resonance Imaging
30%
Antiphospholipid Syndrome
27%
Immunosuppressive Treatment
27%
Finger Joint
26%
Lupus Erythematosus
26%
Clinical Feature
26%
Granulomatosis with Polyangiitis
25%
Biological Marker
24%
Rheumatic Disease
24%
Cohort Analysis
23%
Lupus Nephritis
22%
Hepatitis E Virus
22%
Rituximab
22%
Observational Study
22%
Microscopic Polyangiitis
22%
Thrombosis
19%
Lung Artery Pressure
17%
Antiphospholipid Antibody
15%
Odds Ratio
14%
Cyclophosphamide
14%
Vasculitis
14%
Metacarpophalangeal Joint
13%
Retrospective Cohort Study
13%
Cardiac Catheterization
13%
Disease Activity
13%
Polycyclic Aromatic Hydrocarbon
13%
Heart Disease
12%
Heart Failure with Preserved Ejection Fraction
11%
Platelet
11%
Prognostication
11%
Myocardial Disease
11%
Cancer
11%
Cartilage Degeneration
11%
Whole Body MRI
11%
Tumor Marker
11%
Enteritis
11%
Nintedanib
11%
Mixed Connective Tissue Disease
11%
Catheterization
11%
Clinical Study
11%
Venous Thromboembolism
11%
Cluster Analysis
11%
Keyphrases
Remission Induction
26%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
25%
ANCA-associated Vasculitis
25%
Japanese Patients
22%
4th Edition
22%
Systemic Sclerosis
22%
Autophagy
22%
Rituximab
22%
Pulmonary Arterial Hypertension
17%
Clinical Features
13%
Systemic Lupus Erythematosus
13%
Cyclophosphamide
13%
Systemic Sclerosis-associated Pulmonary Arterial Hypertension
13%
Induction Therapy
13%
Retrospective Cohort Study
12%
Retrospective Analysis
12%
Immunosuppressive Therapy
11%
Phase II Trial
11%
Destructive Arthritis
11%
RASGRP2
11%
Complement Components
11%
Pulmonary Arteritis
11%
Treatment Prediction
11%
Myofascia
11%
Remission
11%
Whole-body MRI
11%
Mx1 Protein
11%
Cardiomyopathy
11%
CalDAG-GEFI
11%
Power Doppler Signal
11%
Lupus Enteritis
11%
Ultrasonographic Features
11%
Signal Assessment
11%
MicroRNA-9
11%
MiR-9
11%
Partial Images
11%
Corticocortical
11%
Intermediary Factors
11%
Risedronate Sodium
11%
Phase Correlation
11%
Treatment-related
11%
I-domain
11%
Cardiac Magnetic Resonance
11%
Glycoprotein I
11%
Maintenance Safety
11%
Ribophorin II
11%
Posterior Reversible Encephalopathy Syndrome
11%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
11%
Disease-associated
11%
Reliability Study
11%
